Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. Yvis platform overview

Published byΚαλλιστώ Σερπετζόγλου Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1. Yvis platform overview"— Presentation transcript:

1 Figure 1. Yvis platform overview
Figure 1. Yvis platform overview. (A) The data input box presents two possibilities to input sequences to be analysed ... Figure 1. Yvis platform overview. (A) The data input box presents two possibilities to input sequences to be analysed in Yvis (user input files and selection from the Yvis database). It presents filter options for sequences from the Yvis database (redundancy and engineered chains) and actions taken by the platform to process the user input files. (B) The analysis box presents the options to visualize a multiple sequence alignment of antibody variable domains and the filter possibilities. The user can generate a new subset of sequences to be analysed, by selecting specific filters. The analysis can be displayed by the Collier de Diamants on one or two layers (I). Additionally, the user can compare the multiple sequence alignment with a reference sequence (II), and visualize data on putative contacts with the antigen (III). Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact Nucleic Acids Res, gkz387, The content of this slide may be subject to copyright: please see the slide notes for details.

2 Figure 2. Collier de Diamants representation of antibody sequences obtained from HIV-infected patients. (A) ... Figure 2. Collier de Diamants representation of antibody sequences obtained from HIV-infected patients. (A) Visualization of the alignment of 97 751 heavy chain sequences derived from the IGHV1-2*02 allele. Positions between and and positions between and were omitted. The box presents part of the detailed bar chart for position 36 showing the residue frequency in this position. (B) Visualization of the alignment of 21 heavy chain sequences of HIV neutralizing antibodies. In both visualizations, the IGHV1-2*02 germline sequence was used as comparison sequence. As this sequence includes only the V gene portion of the variable domain, gaps were inserted in the comparison sequence. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact Nucleic Acids Res, gkz387, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Figure 1. Yvis platform overview"

Similar presentations

Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.

Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.
Figure 1. Unified models predicting gene regulation based on landscapes of gene-regulating factors. For each gene, position specific combinatorial patterns.

Figure 1. Unified models predicting gene regulation based on landscapes of gene-regulating factors. For each gene, position specific combinatorial patterns.
From: Learning by Working in Big Cities

From: Learning by Working in Big Cities
Fig. 1 Nodes in a conceptual knowledge graph

Fig. 1 Nodes in a conceptual knowledge graph
Figure 1: Pneumomediastinum and subcutaneous emphysema as indicated by the arrows. From: Pneumomediastinum and subcutaneous emphysema after successful.

Figure 1: Pneumomediastinum and subcutaneous emphysema as indicated by the arrows. From: Pneumomediastinum and subcutaneous emphysema after successful.
From: Detection of Bacteriuria by Canine Olfaction

From: Detection of Bacteriuria by Canine Olfaction
From: Introducing the PRIDE Archive RESTful web services

From: Introducing the PRIDE Archive RESTful web services
Figure 1. The flow chart illustrates the construction process of anti-CRISPRdb, and the information that users can obtain from anti-CRISPRdb. From: Anti-CRISPRdb:

Figure 1. The flow chart illustrates the construction process of anti-CRISPRdb, and the information that users can obtain from anti-CRISPRdb. From: Anti-CRISPRdb:
Figure 2. Workflow of MethMotif Batch Query

Figure 2. Workflow of MethMotif Batch Query
Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.

Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.
Figure 1. (A) The VEGF promoter PQS and scheme of G oxidation to OG, as well as (B) the proposed APE1-dependent pathway ... Figure 1. (A) The VEGF promoter.

Figure 1. (A) The VEGF promoter PQS and scheme of G oxidation to OG, as well as (B) the proposed APE1-dependent pathway ... Figure 1. (A) The VEGF promoter.
Figure 1. Circular taxonomy tree based on the species that were sequenced in our study. Unless provided in the caption above, the following copyright applies.

Figure 1. Circular taxonomy tree based on the species that were sequenced in our study. Unless provided in the caption above, the following copyright applies.
ADAb: anti-drug antibody.

ADAb: anti-drug antibody.
Figure 1. Overview of the workflow of NetworkAnalyst 3.0.

Figure 1. Overview of the workflow of NetworkAnalyst 3.0.
FIGURE 1 Kidney biopsies of Patients 1 and 2

FIGURE 1 Kidney biopsies of Patients 1 and 2
Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.

Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.
FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.

FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.
Figure 1. Position and number of NLS improves genome editing by AsCas12a, LbCas12a and FnoCas12a. (A) General schematic ... Figure 1. Position and number.

Figure 1. Position and number of NLS improves genome editing by AsCas12a, LbCas12a and FnoCas12a. (A) General schematic ... Figure 1. Position and number.
FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels

FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels
FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:

FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:

Similar presentations

Ads by Google